论文部分内容阅读
KantarjianH,etal.Cancer,2004Dec,101(12),27882801本文综合分析了应用大剂量环磷酰胺、长春新碱、阿霉素和地塞米松(hyper CVAD)强化疗法治疗成人ALL的最新数据以了解其预后情况。设计和方法:作者观察了1992~2000年期间应用hyper CVAD方案治疗的288例成人ALL病人,中位年龄为
Kantarjian H, et al. Cancer, 2004 Dec, 101 (12), 27882801 This review summarizes the latest data on the use of high-dose cyclophosphamide, vincristine, doxorubicin, and hyper CVAD intensive therapy in adults with ALL Its prognosis. DESIGN AND METHODS: The authors looked at 288 adult ALL patients treated with the hyper CVAD regimen between 1992 and 2000 with a median age of